218 results
Keyword Fulvestrant Teva Remove keyword
-
List item
EudraVigilance Information Day
European Medicines Agency, London, UK, 08/11/2016, Last updated: 26/09/2016Person for Pharmacovigilance, Teva Pharmaceuticals Europe B.V … Discussion/Q&A Discussants: Wendy Huisman, TEVA, Margaret Walters, MSD, Sarah … Discussion/Q&A Discussants: Wendy Huisman, TEVA, Margaret Walters, MSD, Sarah … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 31 August-3 September 2020
Virtual meeting, from 31/08/2020 to 03/09/2020, Last updated: 27/02/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 9-12 November 2020
Virtual meeting, from 09/11/2020 to 12/11/2020, Last updated: 07/01/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 April 2018
European Medicines Agency, London, UK, from 23/04/2018 to 26/04/2018, Last updated: 08/06/2018 -
List item
Information day on new services and systems in pharmacovigilance: preparing for business change
European Medicines Agency, London, UK, 28/04/2015, Last updated: 23/03/2015WHO–UMC Discussant: Wendy Huisman, Teva, member of EV-EWG 12:15 SANDWICH … of EV-EWG Wendy Huisman, Teva, member of EV-EWG Veronique … EMA Discussant: Wendy Huisman, Teva, member of EV-EWG Gilles Touraille … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 14-17 May 2018
European Medicines Agency, London, UK, from 14/05/2018 to 17/05/2018, Last updated: 14/05/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 July 2020
European Medicines Agency, Amsterdam, the Netherlands, from 06/07/2020 to 09/07/2020, Last updated: 10/12/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 June 2018
European Medicines Agency, London, UK, from 11/06/2018 to 14/06/2018, Last updated: 10/08/2018 -
List item
Management Board meeting: 16 March 2017
European Medicines Agency, London, UK, 16/03/2017, Last updated: 03/04/2017 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2014
European Medicines Agency, London, UK, from 07/04/2014 to 10/04/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 25-29 September 2017
European Medicines Agency, London, UK, from 25/09/2017 to 29/09/2017, Last updated: 06/09/2017 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 February 2014
European Medicines Agency, London, UK, from 03/02/2014 to 06/02/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 27-30 September 2021
European Medicines Agency, Amsterdam, the Netherlands, from 27/09/2021 to 30/09/2021, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 March 2014
European Medicines Agency, London, UK, from 03/03/2014 to 06/03/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 May 2016
European Medicines Agency, London, UK, from 10/05/2016 to 13/05/2016, Last updated: 13/03/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 March 2018
European Medicines Agency, London, UK, from 19/03/2018 to 22/03/2018, Last updated: 31/05/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 April 2017
European Medicines Agency, London, UK, from 03/04/2017 to 06/04/2017, Last updated: 13/03/2014 -
List item
EudraVigilance information day
European Medicines Agency, London, UK, 21/06/2016, Last updated: 11/03/2016Person for Pharmacovigilance, Teva Pharmaceuticals Europe B.V … Discussion/Q&A Discussants: Wendy Huisman, Teva Pharmaceuticals, NL, Anja … Walters, MSD, UK, Wendy Huisman, Teva Pharmaceuticals, NL, and … -
List item
Committee for Medicinal Products for Human Use (CHMP): 17-20 February 2014
European Medicines Agency, London, UK, from 17/02/2014 to 20/02/2014, Last updated: 09/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 November 2015
European Medicines Agency, London, UK, from 03/11/2015 to 06/11/2015, Last updated: 13/03/2014CAP); BUDSONIDE FORMOTEROL TEVA (CAP); DUORESP SPIROMAX (CAP … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 September 2014
European Medicines Agency, London, UK, from 08/09/2014 to 11/09/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/07/2021 to 08/07/2021, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 February 2015
European Medicines Agency, London, UK, from 09/02/2015 to 12/02/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 September 2016
European Medicines Agency, London, UK, from 26/09/2016 to 29/09/2016, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 January 2015
European Medicines Agency, London, UK, from 06/01/2015 to 09/01/2015, Last updated: 13/03/2014